Excessive alcohol intake, a defining characteristic of an alcohol use disorder (AUD), results in neurodegeneration in the hippocampus and entorhinal cortex that has been linked to a variety of cognitive deficits. Neuroinflammation is thought to be a factor in alcohol-induced neurodegeneration, and microglia activation is a key but not sole component of an inflammatory response. These experiments investigate the effects of ethanol exposure in a well-accepted model of an AUD on both microglial activation and blood brain barrier disruption (BBB) in order to understand their relationship to classical definitions of inflammation and alcohol-induced neurodegeneration. Following a four-day binge ethanol paradigm, rat hippocampal and entorhinal cortex tissue was examined using three distinct approaches to determine microglia phenotype and BBB disruption: immunohistochemistry, autoradiography, and ELISA. After ethanol exposure, there was an increase in [ 3 H]-PK-11195 binding and OX-42 immunoreactivity indicative of microglial activation; however, microglia were not fully activated since both OX-6 and ED-1 immunoreactive microglia were absent. This data was supported by functional evidence as there was no increase in the proinflammatory cytokines IL-6 or TNF-α, but a 26% increase in the anti-inflammatory cytokine, IL-10, and a 38% increase in the growth factor, TGF-β, seven days after exposure. Furthermore, there was no evidence of a disruption of the BBB. These data suggest that the four-day binge model of an AUD, which produces neurodegeneration in corticolimbic regions, does not elicit classical neuroinflammation but instead produces partially activated microglia. Partial activation of microglia following binge ethanol exposure suggest that microglia in this model have beneficial or homeostatic roles rather than directly contributing to neurodegeneration and are a consequence of alcohol-induced-damage instead of the source of damage.
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Introduction
Whether microglial activation is the cause or consequence of neurodegeneration is hotly debated in studies of neurodegenerative disease. Although not traditionally classified as a neurodegenerative disease due to its preventable nature, alcohol use disorders (AUDs) and specifically the characteristic excessive consumption of alcohol, result in corticolimbic neurodegeneration that underlies a variety of cognitive deficits in alcoholics (Crews and Nixon, 2009; Obernier et al., 2002a; Pfefferbaum et al., 1992; Sullivan et al., 1995) . As alcohol-induced neurodegeneration is thought to be a critical step in the development of an AUD (Crews, 1999; Crews and Boettiger, 2009; Koob and Le Moal, 1997) , understanding how excessive alcohol consumption results in neuronal loss is crucial for the development of prevention and treatment strategies. It has been hypothesized that alcoholinduced neuroinflammation directly contributes to neurodegeneration and the development of AUDs (Crews et al., 2011) . Neuroinflammation has been inferred from the upregulation of a variety of proinflammatory genes and cytokines involved in the innate immune system (Crews et al., 2006; He and Crews, 2008; Knapp and Crews, 1999; Qin et al., 2008) . For example, chronic ethanol exposure induces innate immune signaling cascades through activation of the proinflammatory transcription factor nuclear factor-kappa B (NFκB; Crews et al., 2006 Crews et al., , 2011 Valles et al., 2004) . Others have shown that a variety of proinflammatory signals are associated with increased ethanol drinking and preference (Blednov et al., 2012) and that peripheral inflammation promotes increases in voluntary ethanol intake whereas anti-inflammatory administration reduces its consumption (Agrawal et al., 2011; Blednov et al., 2011) . However, remarkably little is known about the effects of alcohol on microglia, the primary mediators of the innate immune system in the brain. 
